Publications by authors named "Ruben D de Ruiter"

Claim this Profile
V
Validation of quantitative [F]NaF PET uptake parameters in bone diseases: a systematic review.
Ruben D de Ruiter, Jolien Zwama, Pieter G H M Raijmakers, Maqsood Yaqub, George L Burchell

Ann Nucl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eagle syndrome: tissue characteristics and structure of the styloid process.
Ruben D de Ruiter, Sanne Treurniet, Nathalie Bravenboer, Björn Busse, Jan Jaap Hendrickx

JBMR Plus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders.
Jolien Zwama, Neeltje M Rosenberg, Vincent A Verheij, Pieter G H M Raijmakers, Maqsood Yaqub, Ruben D de Ruiter

Biomolecules· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of simplified methods for quantification of [F]NaF uptake in fibrodysplasia ossificans progressiva.
Ruben Daniel de Ruiter, Esmée Botman, Bernd P Teunissen, Adriaan Anthonius Lammertsma, Ronald Boellaard

Front Nucl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results from the Phase 2 LUMINA-1 Trial.
Yuhuan Wang, Jenny-Hoa Nguyen, Ruben D de Ruiter, Jeanne Mendell, Dushyanth Srinivasan

J Clin Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-Beta Induces Activin A Production in Dermal Fibroblasts Derived from Patients with Fibrodysplasia Ossificans Progressiva.
Ruben D de Ruiter, Lisanne E Wisse, Ton Schoenmaker, Maqsood Yaqub, Gonzalo Sánchez-Duffhues

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.
Elisabeth M W Eekhoff, Ruben D de Ruiter, Bernard J Smilde, Ton Schoenmaker, Teun J de Vries

Hum Gene Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives.
Bernard J Smilde, Esmée Botman, Ruben D de Ruiter, Jan Maerten Smit, Berend P Teunissen

Orthop Res Rev· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
Ruben D de Ruiter, Bernard J Smilde, Gerard Pals, Nathalie Bravenboer, Petra Knaus

Front Endocrinol (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI.
Ruben D de Ruiter, M Suzanne Gordijn, Reinoud J B J Gemke, Cor van den Bos, Marc B Bierings

Haematologica· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis